Genetic Technologies Limited (GENE)

Genetic Technologies Income Statement

Financials in millions AUD. Fiscal year is July - June.

Year	2023	2022	2021	2020	2019
Revenue	8.69	6.79	0.12	0.01	0.03
Revenue Growth (YoY)	27.83%	5536.33%	1122.16%	-61.23%	-86.56%
Cost of Revenue	4.34	3.01	0.17	0.1	0.28
Gross Profit	4.35	3.78	-0.05	-0.09	-0.25
Selling, General & Admin	9.16	7.91	4.3	2.35	4.41
Research & Development	2.64	2.54	2.63	2.9	2.36
Other Operating Expenses	6.49	3.3	1.7	2.03	0
Operating Expenses	18.29	13.75	8.63	7.27	6.77
Operating Income	-13.94	-9.97	-8.68	-7.36	-7.02
Interest Expense / Income	0.03	0.02	0.02	0.07	0.02
Other Expense / Income	-2.06	-2.82	-1.62	-1.14	-0.61
Pretax Income	-11.91	-7.16	-7.08	-6.29	-6.43
Income Tax	-0.16	-0.03	0	0	0
Net Income	-11.75	-7.13	-7.08	-6.29	-6.43
Shares Outstanding (Basic)	101	92	85	42	26
Shares Outstanding (Diluted)	101	92	85	42	26
Shares Change	9.95%	7.91%	105.63%	57.66%	8.22%
EPS (Basic)	-7.20	-48.00	-48.00	-90.00	-144.00
EPS (Diluted)	-7.20	-48.00	-48.00	-90.00	-144.00
Free Cash Flow	-9.74	-5.72	-7.04	-5.71	-6.12
Free Cash Flow Per Share	-57.65	-37.24	-49.47	-82.50	-139.41
Gross Margin	50.09%	55.65%	-41.39%	-928.32%	-985.78%
Operating Margin	-160.45%	-146.69%	-7203.11%	-74648.82%	-27581.59%
Profit Margin	-135.28%	-104.95%	-5870.91%	-63815.64%	-25253.91%
Free Cash Flow Margin	-112.14%	-84.23%	-5843.55%	-57919.69%	-24066.54%
EBITDA	-11.88	-7.15	-7.06	-6.22	-6.41
EBITDA Margin	-136.77%	-105.20%	-5857.36%	-63084.90%	-25175.18%
EBIT	-11.88	-7.15	-7.06	-6.22	-6.41
EBIT Margin	-136.77%	-105.20%	-5857.36%	-63084.90%	-25175.18%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).